Bank of New York Mellon’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $427K | Buy |
|
|||||
|
2025
Q2 | $355K | Sell |
|
|||||
|
2025
Q1 | $286K | Buy |
|
|||||
|
2024
Q4 | $517K | Sell |
|
|||||
|
2024
Q3 | $951K | Sell |
|
|||||
|
2024
Q2 | $1.11M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $11.9K | Hold |
|
|||||
|
2023
Q1 | $10.1K | Hold |
|
|||||
|
2022
Q4 | $7.32K | Hold |
|
|||||
|
2022
Q3 | $9K | Sell |
|
|||||
|
2022
Q2 | $15K | Sell |
|
|||||
|
2022
Q1 | $218K | Sell |
|
|||||
|
2021
Q4 | $570K | Sell |
|
|||||
|
2021
Q3 | $887K | Buy |
|
|||||
|
2021
Q2 | $1.06M | Sell |
|
|||||
|
2021
Q1 | $1.43M | Sell |
|
|||||
|
2020
Q4 | $1.68M | Buy |
|
|||||
|
2020
Q3 | $1.34M | Sell |
|
|||||
|
2020
Q2 | $1.95M | Buy |
|
|||||
|
2020
Q1 | $259K | Buy |
|
|||||
|
2019
Q4 | $195K | Sell |
|
|||||
|
2019
Q3 | $47K | Hold |
|
|||||
|
2019
Q2 | $39K | Hold |
|
|||||
|
2019
Q1 | $44K | Sell |
|
|||||
|
2018
Q4 | $37K | Hold |
|
|||||
|
2018
Q3 | $50K | Hold |
|
|||||
|
2018
Q2 | $45K | Sell |
|
|||||
|
2018
Q1 | $301K | Buy |
|
|||||
|
2017
Q4 | $200K | Sell |
|
|||||
|
2017
Q3 | $330K | Hold |
|
|||||
|
2017
Q2 | $327K | Buy |
|
|||||
|
2017
Q1 | $333K | Sell |
|
|||||
|
2016
Q4 | $331K | Buy |
|
|||||
|
2016
Q3 | $224K | Sell |
|
|||||
|
2016
Q2 | $115K | Sell |
|
|||||
|
2016
Q1 | $240K | Buy |
|
|||||
|
2015
Q4 | $217K | Hold |
|
|||||
|
2015
Q3 | $244K | Buy |
|